Silihan lan utang jangka dawa perusahaan: IRIDEX Corporation (IRIX)

The price trend illustrated in this chart reflects the dynamics of IRIDEX Corporation (IRIX), whose business model relies on the sale of laser systems and ancillary consumables, ensuring a steady profit stream. The current metric stands at -0.00. Production is concentrated at the California plant, featuring strict sterility controls and a strategic reserve of components. The company is currently promoting mature MicroPulse technologies for retinal and glaucoma therapy.

This indicator is indispensable for stress-testing debt loads and filtering assets with a high risk of default. The metric measures total credit obligations with a maturity of more than one year, whereby the long-term financial debt of IRIDEX Corporation (IRIX) in the amount of -0.00 reflects the company's ability to finance the development of the premium ophthalmology segment through borrowed capital, relying on stable revenues from the sale of patented systems and consumables.